BR0112413A - Derivados de variolina como agentes anticâncer - Google Patents

Derivados de variolina como agentes anticâncer

Info

Publication number
BR0112413A
BR0112413A BR0112413-7A BR0112413A BR0112413A BR 0112413 A BR0112413 A BR 0112413A BR 0112413 A BR0112413 A BR 0112413A BR 0112413 A BR0112413 A BR 0112413A
Authority
BR
Brazil
Prior art keywords
substituted
group
unsubstituted
variolin
new
Prior art date
Application number
BR0112413-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Jonathan Charles Morris
Regan James Anderson
Modesto Remunan
Ignacio Manzanares
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0017055A external-priority patent/GB0017055D0/en
Priority claimed from GB0030689A external-priority patent/GB0030689D0/en
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of BR0112413A publication Critical patent/BR0112413A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR0112413-7A 2000-07-11 2001-07-11 Derivados de variolina como agentes anticâncer BR0112413A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0017055A GB0017055D0 (en) 2000-07-11 2000-07-11 Synthesis
GB0030689A GB0030689D0 (en) 2000-12-15 2000-12-15 Synthesis
PCT/GB2001/003111 WO2002004447A1 (en) 2000-07-11 2001-07-11 Variolin derivatives as anti-cancer agents

Publications (1)

Publication Number Publication Date
BR0112413A true BR0112413A (pt) 2003-05-27

Family

ID=26244637

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0112413-7A BR0112413A (pt) 2000-07-11 2001-07-11 Derivados de variolina como agentes anticâncer

Country Status (20)

Country Link
US (1) US7320981B2 (enExample)
EP (1) EP1299388B1 (enExample)
JP (1) JP2004502773A (enExample)
KR (1) KR100886161B1 (enExample)
CN (1) CN1324028C (enExample)
AT (1) ATE431349T1 (enExample)
AU (3) AU2001270783B2 (enExample)
BR (1) BR0112413A (enExample)
CA (1) CA2414200C (enExample)
CY (1) CY1109283T1 (enExample)
DE (1) DE60138707D1 (enExample)
DK (1) DK1299388T3 (enExample)
ES (1) ES2327210T3 (enExample)
IL (2) IL153682A0 (enExample)
MX (1) MXPA03000341A (enExample)
NZ (1) NZ523491A (enExample)
PT (1) PT1299388E (enExample)
RU (1) RU2299884C2 (enExample)
SI (1) SI1299388T1 (enExample)
WO (1) WO2002004447A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0019117D0 (en) * 2000-08-03 2000-09-27 Univ Barcelona Derivatives of variolin B
GB0116966D0 (en) * 2001-07-11 2001-09-05 Pharma Mar Sa Anittumoral compounds
CA2526285A1 (en) 2003-05-15 2004-12-23 Arqule, Inc. Inhibitors of p38 and methods of using the same
US7829560B2 (en) 2004-07-08 2010-11-09 Arqule, Inc. 1,4-disubstituted naphthalenes as inhibitors of P38 MAP kinase
US8178672B2 (en) 2004-10-19 2012-05-15 Arqule, Inc. Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 MAP kinase
EP1666467A1 (en) * 2004-11-08 2006-06-07 Evotec AG 11Beta-HSD1 Inhibitors
WO2006075591A1 (ja) * 2005-01-12 2006-07-20 Kuraray Co., Ltd. 樹脂組成物及びそれからなるフィルム
PL1896470T3 (pl) * 2005-05-16 2011-03-31 Irm Llc Pochodne pirolopirydynowe jako inhibitory kinazy białkowej
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ236494A3 (en) * 1992-04-03 1994-12-15 Upjohn Co Pharmaceutically active bicyclic-heterocyclic amines
GB0019117D0 (en) * 2000-08-03 2000-09-27 Univ Barcelona Derivatives of variolin B
GB0116966D0 (en) 2001-07-11 2001-09-05 Pharma Mar Sa Anittumoral compounds

Also Published As

Publication number Publication date
KR100886161B1 (ko) 2009-02-27
RU2299884C2 (ru) 2007-05-27
SI1299388T1 (sl) 2009-12-31
MXPA03000341A (es) 2004-04-05
AU2001270783B2 (en) 2006-06-15
KR20030017581A (ko) 2003-03-03
AU2006213946A1 (en) 2006-10-05
ES2327210T3 (es) 2009-10-27
EP1299388B1 (en) 2009-05-13
IL153682A0 (en) 2003-07-06
CA2414200A1 (en) 2002-01-17
DE60138707D1 (de) 2009-06-25
WO2002004447A1 (en) 2002-01-17
US20050014778A1 (en) 2005-01-20
AU2006213946B2 (en) 2008-01-10
CA2414200C (en) 2010-05-04
AU7078301A (en) 2002-01-21
ATE431349T1 (de) 2009-05-15
PT1299388E (pt) 2009-08-13
CN1630658A (zh) 2005-06-22
DK1299388T3 (da) 2009-08-31
CY1109283T1 (el) 2014-07-02
CN1324028C (zh) 2007-07-04
EP1299388A1 (en) 2003-04-09
IL153682A (en) 2010-05-31
US7320981B2 (en) 2008-01-22
NZ523491A (en) 2004-06-25
JP2004502773A (ja) 2004-01-29

Similar Documents

Publication Publication Date Title
MXPA04001240A (es) Analogos antitumorales.
TR200200749T2 (tr) Kinazolin bileşikleri ve bunları içeren farmasötik bileşikler.
NO155243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater.
EP1117297A4 (en) ECTEINASCIDIN-743 SYNTHETIC ANALOGS
BR0308983A (pt) Compostos de aril-alquina como herbicidas
ES8308311A1 (es) Procedimiento para la preparacion de derivados de benzazepina.
TR200400859T4 (tr) Yeni heterosiklik bileşikler, özellikle antibakteriyel preparatları.
BRPI0413164A (pt) composições bioativas compreendendo as triazinas
BRPI0606367A2 (pt) derivados espirocetais e composições farmacêuticas compreendendo os mesmos
DE60221098D1 (de) Kondensierte heterocyclische derivate
BRPI0606319A2 (pt) compostos farmacêuticos
RU2000127751A (ru) Противоопухолевое средство
BR0112413A (pt) Derivados de variolina como agentes anticâncer
ATE325796T1 (de) Derivate von triazolyl-imidazopyridine und von triazolylpurine als ligande des adenosine a2a rezeptoren und ihre verwendung als medicamente
FR2379581A1 (fr) Colorants fluorescents derives de la coumarine
ATE371661T1 (de) Tumorhemmende derivate von et-743
BRPI0514430A (pt) composto de rutênio (ii) ou um solvato ou pró-droga do mesmo, composição, uso de um composto, e, método de tratamento de um indivìduo que sofre de cáncer
BR9813923A (pt) N n - bis(sulfonil) hidrazinas úteis como agentes antineoplásicos
PL366894A1 (en) Variolin derivatives and their use as antitumor agents
Ray et al. Novel synthetic aromatic thiourea derivatives and investigations on their cytotoxic potential efficacy
BRPI0512632A (pt) processo para a preparação de biarildifosfinas assimetricamente substituìdas
BR9910859A (pt) Derivados de cianoiminoquinoxalina
BR0108448A (pt) Derivados de tetraidrofuril óxi-e amino-substituìdos com atividade antitumor
DE60026161D1 (de) Amidin-derivate, ihre herstellung und verwendung als medikamenten
BR0108128A (pt) Pluraflavinas e derivados das mesmas, processo para a sua preparação e uso das mesmas

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements